Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody

Who we are

  • November 15, 2022
    Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer (STELLAR-303)